![DNAtrix begins Phase II trial of DNX-2401 and KEYTRUDA to treat recurrent glioblastoma - Clinical Trials Arena DNAtrix begins Phase II trial of DNX-2401 and KEYTRUDA to treat recurrent glioblastoma - Clinical Trials Arena](https://www.drugdevelopment-technology.com/wp-content/uploads/image-digitalinsightresearch/Active/2016Q3/2.NRI/Drug%20development/News/Core%20News/November/Glioblastoma%202%20Nov.jpg)
DNAtrix begins Phase II trial of DNX-2401 and KEYTRUDA to treat recurrent glioblastoma - Clinical Trials Arena
![Merck receives EC approval for Keytruda to treat relapsed Hodgkin Lymphoma - Pharmaceutical Technology Merck receives EC approval for Keytruda to treat relapsed Hodgkin Lymphoma - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2017/09/main-1249.jpg)
Merck receives EC approval for Keytruda to treat relapsed Hodgkin Lymphoma - Pharmaceutical Technology
![Lung Cancer Surgery Can Be Beneficial for High-Risk Patients with Early Stage Disease | The Patient Guide to Heart, Lung, and Esophageal Surgery Lung Cancer Surgery Can Be Beneficial for High-Risk Patients with Early Stage Disease | The Patient Guide to Heart, Lung, and Esophageal Surgery](https://ctsurgerypatients.org/sites/default/files/NCI%20Chest%20Xray%20Cancer_0.jpg)
Lung Cancer Surgery Can Be Beneficial for High-Risk Patients with Early Stage Disease | The Patient Guide to Heart, Lung, and Esophageal Surgery
![Clinical trial co-led by UCL leads to new bowel cancer drug approval | UCL News - UCL – University College London Clinical trial co-led by UCL leads to new bowel cancer drug approval | UCL News - UCL – University College London](https://www.ucl.ac.uk/news/sites/news/files/styles/medium_image/public/pembrolizumab-image_wiki.jpg?itok=UCdIs0kK)